|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,286.90 INR | -0.46% |
|
+0.87% | +12.37% |
| 07-07 | India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law | RE |
| 07-06 | Glenmark Pharmaceuticals Launches Olanzapine for Injection | MT |
| Market Cap | 648B 6.74B 5.89B 5.43B 5B 9.47B 9.63B 64.88B 25.46B 317B 25.3B 24.75B 1,092B | P/E 2026 |
44.2x | P/E 2027 * | 27.6x |
|---|---|---|---|---|---|
| Enterprise Value | 609B 6.33B 5.53B 5.1B 4.69B 8.89B 9.04B 60.94B 23.91B 298B 23.77B 23.25B 1,026B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.67x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.23% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -0.46% | ||
| 1 week | +0.87% | ||
| Current month | +3.75% | ||
| 1 month | +6.04% | ||
| 3 months | +1.66% | ||
| 6 months | +14.30% | ||
| Current year | +12.37% |
| 1 week | 2,247 |  | 2,326.1 |
| 1 month | 2,101 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 695 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46% | +0.87% | +3.72% | +225.58% | 6.74B | |
| -0.07% | +0.59% | +14.64% | +80.97% | 48.66B | |
| +0.59% | -0.41% | +67.38% | +112.51% | 35.52B | |
| -0.59% | -0.82% | -3.14% | +38.43% | 12.07B | |
| -0.26% | -0.44% | +19.09% | +91.34% | 11.99B | |
| +1.32% | +1.15% | +32.83% | +126.50% | 9.29B | |
| -1.76% | -4.19% | +41.36% | -6.88% | 6.92B | |
| +0.42% | +0.50% | +19.64% | +38.14% | 7B | |
| +6.39% | +7.36% | -16.52% | +20.63% | 6.36B | |
| -0.04% | +4.39% | +23.85% | +140.87% | 4.48B | |
| Average | +0.55% | +1.75% | +20.29% | +86.81% | 14.9B | |
| Weighted average by Cap. | +0.32% | +1.33% | +27.19% | +88.38% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.59B 1.39B 1.28B 1.18B 2.24B 2.27B 15.32B 6.01B 74.84B 5.98B 5.84B 258B | 167B 1.73B 1.51B 1.4B 1.28B 2.43B 2.48B 16.68B 6.55B 81.49B 6.51B 6.36B 281B |
| Net income | 20.53B 213M 187M 172M 158M 300M 305M 2.05B 806M 10.04B 801M 784M 34.59B | 23.28B 242M 212M 195M 179M 340M 346M 2.33B 914M 11.38B 909M 889M 39.22B |
| Net Debt | -39.29B -408M -357M -329M -303M -574M -583M -3.93B -1.54B -19.21B -1.53B -1.5B -66.2B | -37.12B -386M -337M -311M -286M -542M -551M -3.71B -1.46B -18.14B -1.45B -1.42B -62.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | ₹2,286.90 | -0.46% | 158,181 |
| 15/07/26 | ₹2,297.40 | -0.33% | 491,365 |
| 14/07/26 | ₹2,305.10 | +0.17% | 706,821 |
| 13/07/26 | ₹2,301.30 | +0.81% | 720,659 |
| 10/07/26 | ₹2,282.90 | +0.69% | 602,305 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
